🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study to determine if using the (18)F-rhPSMA-7.3 PET-CT sc...
Status
Recruiting
Location
UF Health - Jacksonville
Start Date
2025-11-04
Trial ID
NCT07220720
Treatments Being Tested
Flotufolastat F-18, sold under the brand name Posluma, is a radioactive dia...
Status
Recruiting
Location
AdventHealth
Start Date
2024-09-20
Trial ID
NCT06617481
Treatments Being Tested
This prospective pilot study will assess the feasibility of rh PSMA 7.3 pos...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-08-04
Trial ID
NCT04978675
Treatments Being Tested
This investigator-initiated, prospective study evaluates the diagnostic uti...
Status
Recruiting
Location
Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai
Start Date
2026-02-10
Trial ID
NCT07285057
Treatments Being Tested
This phase II trial evaluates Fluorine-18 radiohybrid prostate-specific mem...
Status
Active Not Recruiting
Location
Emory University Hospital Midtown
Start Date
2023-04-27
Trial ID
NCT05779943
Treatments Being Tested
This clinical trial evaluates \[18F\]-rh PSMA positron emission tomography ...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2025-03-25
Trial ID
NCT06580015
This phase II trial studies how well a short course of androgen deprivation...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2025-08-25
Trial ID
NCT07025369
This phase II trial evaluates an imaging technique (rhPSMA-7.3 positron emi...
Status
Recruiting
Location
Northwestern University
Start Date
2025-04-11
Trial ID
NCT06813898
This clinical trial evaluates whether positron emission tomography-magnetic...
Status
Recruiting
Location
Northwestern University
Start Date
2023-06-07
Trial ID
NCT05852041
To determine the dose, safety, radiation dosimetry and efficacy of 177Lu-rh...
Status
Recruiting
Location
Biogenix Molecular LLC
Start Date
2022-07-20
Trial ID
NCT05413850
Treatments Being Tested